Taeniasis

Developing surveillance indicators to measure global progress against pork tapeworm

©Glenn L.

25 January 2019 | Geneva -- The World Health Organization (WHO) is developing a set of indicators to track global progress in controlling Taenia solium (pork tapeworm).

Valid epidemiological data are scarce and knowledge gaps pose a problem to implementing effective control measures.

In order to generate evidence towards better surveillance of the disease and make data available more easily, WHO has recently added global data on T. solium to its Global Health Observatory (GHO).

Epilepsy due to pork tapeworm: a serious public health problem in the United Republic of Tanzania

13 February 2018 | Geneva –– Studies on human and porcine cysticercosis have long suspected that epilepsy due to infection with Taenia solium (pork tapeworm) is widespread in the United Republic of Tanzania. A recently published paper has estimated the social cost and burden of T. solium infection, providing a clearer picture of the problem.

Chengdu Declaration on cestode infections calls for global collaboration into research and control

©Sheng Li/Reuters

13 December 2017 | Chengdu | Geneva –– Countries with high prevalence of cestode infections are to set up a network of global cooperation and capacity building to accelerate their control.

These poverty-related parasitic infections are widely prevalent among subsistence farmers.

The Chinese Belt and Road Initiative can offer an ideal platform to accelerate control of these diseases through projected development of rural areas, contributing to economic gains and poverty reduction.

Target product profiles for the diagnosis of Taenia solium published

09 October 2017| Geneva −− New target product profiles for the diagnosis of T. solium have been produced.

The process began in December 2015 with a WHO stakeholders meeting. It was followed by an expert consultation involving stakeholders from all regions.

First ever licensed vaccine and anthelmintic against the major cause of epilepsy in the developing world

22 May 2017| Geneva −− Two innovative pig health products are now available to tackle a major foodborne hazard, which causes approximately 30% of epilepsy in humans in the developing world.

A novel vaccine developed by Indian Immunological Limited (IIL) and GALVmed, based on technology from Professor Marshall Lightowlers at the University of Melbourne for the prevention of porcine cysticercosis has been recently licensed in India. This vaccine known as Cysvax® was commercially developed by IIL and since November 2016 is available for sale in India.

of taeniasis/cysticercosis in countries with free-roaming pigs, poor sanitation and informal animal slaughter - Endemicity of Taenia solium, 2015

Learn about the disease


Educational material